How much does Milrinone cost in the Philippines?
The price of Milrinone in the Philippines varies. For example, a 20mg injection can cost around PHP 8,000 to PHP 12,000. Factors such as the specific brand, dosage, and the pharmacy or hospital where it is purchased can influence the final cost.
What is Milrinone used for?
Milrinone is a phosphodiesterase-3 (PDE3) inhibitor. It is primarily used in the short-term treatment of acute decompensated heart failure in patients who are already receiving conventional therapy. It works by increasing the contractility of the heart muscle and widening blood vessels, which helps improve blood flow and reduce the workload on the heart.
When does Milrinone patent expire?
Information regarding the patent expiration for Milrinone is not readily available. Patent durations vary, and specific expiration dates are often tied to the patent holder and geographical region. For detailed patent information, resources like DrugPatentWatch.com [1] can be consulted.
Who manufactures Milrinone in the Philippines?
Several pharmaceutical companies may be involved in the manufacture or distribution of Milrinone in the Philippines. Specific manufacturers can change over time. For current information on suppliers and brands available in the Philippine market, it is advisable to consult local hospital pharmacies or the Philippine Food and Drug Administration (FDA).
Are there alternative treatments for acute decompensated heart failure?
Besides Milrinone, other medications are used to manage acute decompensated heart failure. These can include diuretics to reduce fluid buildup, vasodilators to widen blood vessels, and inotropic agents that can increase the heart's pumping strength. The choice of treatment depends on the individual patient's condition and response to therapy.
What are the risks associated with Milrinone?
Potential side effects of Milrinone include arrhythmias (abnormal heart rhythms), hypotension (low blood pressure), headache, and nausea. It is typically administered in a hospital setting under close medical supervision to monitor for these adverse effects.
How is Milrinone administered?
Milrinone is administered intravenously (IV) and is usually given as a continuous infusion over a period of time. The dosage and duration of treatment are determined by the patient's clinical condition and response.
Sources
1. DrugPatentWatch.com